首页
> 会议日程详情
东南大学
2025-11-22
1
论文交流（英文）3
[论文发言]
11:10-11:18 
705庐山 
Prognostic Factors and Real-World Effectiveness of Second-Line Regorafenib After TKI Failure in Hepatocellular Carcinoma 查看详情>>